StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Bioxytran market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bioxytran's market cap was $2.57M on Oct 19, 2026, against $6.11M a year earlier. Over the last 5 years it ranged from $54.94K to $62.60M, with a median of $15.30M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$2.57M-61.9%
2025Dec 31, 2025$6.75M-8.8%
2024Dec 31, 2024$7.39M-65.9%
2023Dec 29, 2023$21.65M-63.3%
2022Dec 30, 2022$59.05M+34.4%
2021Dec 31, 2021$43.95M+88.4%
2020Dec 31, 2020$23.32M-3.7%
2019Dec 31, 2019$24.23M-44.2%
2018Dec 31, 2018$43.40M-40.8%
2017Dec 29, 2017$73.32M+350.7%
2016Dec 30, 2016$16.27M-4.7%
2015Dec 31, 2015$17.07M-75.5%
2014Dec 31, 2014$69.80M-79.7%
2013Dec 31, 2013$343.13M+80.1%
2012Dec 31, 2012$190.48M+6.2%
2011Dec 30, 2011$179.36M–

More Bioxytran figures

See a number that looks wrong?